✦ LIBER ✦

Genetic comorbidities in Parkinson's disease

✍ Scribed by Nalls, M. A.; Saad, M.; Noyce, A. J.; Keller, M. F.; Schrag, A.; Bestwick, J. P.; Traynor, B. J.; Gibbs, J. R.; Hernandez, D. G.; Cookson, M. R.; Morris, H. R.; Williams, N.; Gasser, T.; Heutink, P.; Wood, N.; Hardy, J.; Martinez, M.; Singleton, A. B.

Book ID: 121356980
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 380 KB
Volume: 23
Category: Article
ISSN: 0964-6906
DOI: 10.1093/hmg/ddt465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comorbid cancer in Parkinson's disease

✍ Raymond Y. Lo; Caroline M. Tanner; Stephen K. Van Den Eeden; Kathleen B. Albers; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract The aim of this article was to evaluate cancer occurrence before and after diagnosis of Parkinson's disease (PD). We investigated 692 patients newly diagnosed with PD and 761 age‐ and sex‐matched control subjects identified during two periods (1994–1995 and 2000–2003) within Kaiser Perm

Parkinson's Disease || Genetics of Parki

Parkinson's Disease || Genetics of Parkinson's Disease

✍ Ross, Owen A. 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 415 KB

Parkinson’s disease is the second most prevalent neurodegenerative disease and is characterized by the irreversible loss of dopamine neurons. Despite its high prevalence in society and many decades of research, the origin of the pathogenesis and the molecular determinants involved in the disorder ha

Parkinson’s Disease and Nonmotor Dysfunc

Parkinson’s Disease and Nonmotor Dysfunction || Fatigue: A Common Comorbidity in Parkinson’s Disease

✍ Pfeiffer, Ronald F.; Bodis-Wollner, Ivan 📂 Article 📅 2012 🏛 Humana Press 🌐 English ⚖ 237 KB

The first edition of Parkinson’s Disease and Nonmotor Dysfunction was published in 2005 to provide a source of detailed information that could be readily accessed by the practicing physician. The widely praised first edition described and explained these nonmotor features that had at that point rec

Assessing comorbidity in patients with P

Assessing comorbidity in patients with Parkinson's disease

✍ Martine Visser; Johan Marinus; Jacobus J. van Hilten; Ruth G.B. Schipper; Anne M 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

## Abstract The aim of this study was to assess the accuracy of an interview‐based assessment of comorbidity, in patients with Parkinson's disease (PD). The Cumulative Illness Rating Scale‐Geriatric (CIRS‐G) was completed (1) in an interview with 31 PD patients and their caregivers, and (2) by revi

Genetic testing in Parkinson's disease

✍ Aideen McInerney-Leo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

iology was found. Our case documents the occurrence of this unusual myoclonus physiology in biopsy-proven Lafora disease. Indeed, the movement disorder neurophysiology evaluation was more useful in terms of defining a myoclonus physiology than routine EEG. Wilkins and colleagues 4 first described t

Genetic testing in Parkinson's disease

✍ Aideen McInerney-Leo; Donald W. Hadley; Katrina Gwinn-Hardy; John Hardy 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract Parkinson's disease (PD) is a common neurodegenerative disorder of adulthood characterized clinically by rigidity, bradykinesia, resting tremor, and postural instability. The annual incidence of PD ranges between 16 and 19 individuals per 100,000 (Twelves et al., Mov Disord 2003;18:19–3